Virios therapeutics announces research collaboration exploring the potential of combination antiviral therapy for treating long covid

Atlanta--(business wire)---- $viri #covid--virios therapeutics, inc. (nasdaq: viri), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat chronic diseases, including fibromyalgia, announced today a collaboration with the bateman horne center (“bhc”) of salt lake city, utah, to explore the role of combination antiviral therapy in long covid, otherwise known as post-acute sequelae of covid-19 . the bateman horne center is a non-profit, interdisciplinary center of excel
VIRI Ratings Summary
VIRI Quant Ranking